Cargando…

Transcriptional Expressions of CXCL9/10/12/13 as Prognosis Factors in Breast Cancer

CXCLs play critical roles in antitumor immunity by activating tumor-specific immune responses and stimulating tumor proliferation, thus affecting patient outcomes. However, the expression and prognostic values of CXCLs in breast cancer have not been well clarified. The aim of this study was to inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yan, Liang, Mingqiang, Lin, Yuxiang, Lv, Jinxing, Chen, Minyan, Zhou, Peng, Fu, Fangmeng, Wang, Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499319/ https://www.ncbi.nlm.nih.gov/pubmed/32963527 http://dx.doi.org/10.1155/2020/4270957

Ejemplares similares

Associations of Two Common Genetic Variants with Breast Cancer Risk in a Chinese Population: A Stratified Interaction Analysis
por: Lin, Yuxiang, et al.
Publicado: (2014)

A nomogram prediction for the survival of patients with triple negative breast cancer
por: Lin, Yuxiang, et al.
Publicado: (2018)

Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis
por: Lin, Yuxiang, et al.
Publicado: (2020)

Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer
por: Qiu, Lin, et al.
Publicado: (2016)

Overproduction of CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 in β-thalassemia major or patients
por: Najmaddini, Hamid, et al.
Publicado: (2014)

Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis
por: Wang, Chuan, et al.
Publicado: (2013)

Dual HER2 Blockade versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Yu, Liuwen, et al.
Publicado: (2020)

Evaluating the benefits and adverse effects of an enthracycline-taxane-capecitabine combined regimen in patients with early breast cancer
por: Zhang, Jiantang, et al.
Publicado: (2017)

Seminal Levels of Pro-inflammatory (CXCL1, CXCL9, CXCL10) and Homeostatic (CXCL12) Chemokines in Men With Asymptomatic Chlamydia trachomatis Infection
por: Hakimi, Hamid, et al.
Publicado: (2014)

CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1
por: Lin, Yuxiang, et al.
Publicado: (2022)

CXCL8, CXCL9, and CXCL10 serum levels increase in syphilitic patients with seroresistance
por: Dong, Xiaoyan, et al.
Publicado: (2021)

CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
por: Wang, Cuini, et al.
Publicado: (2016)

The Impact of Young Age for Prognosis by Subtype in Women with Early Breast Cancer
por: Lian, Weibin, et al.
Publicado: (2017)

Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
por: Rabquer, Bradley J, et al.
Publicado: (2011)

Expression of chemokine CXCL8/9/10/11/13 and its prognostic significance in head and neck cancer
por: Zhao, Zhenyu, et al.
Publicado: (2022)

Progranulin inhibits expression and release of chemokines CXCL9 and CXCL10 in a TNFR1 dependent manner
por: Mundra, Jyoti Joshi, et al.
Publicado: (2016)

Induction of cathepsin B by the CXCR3 chemokines CXCL9 and CXCL10 in human breast cancer cells
por: Bronger, Holger, et al.
Publicado: (2017)

CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
por: Yu, Xin, et al.
Publicado: (2022)

The Effect of Transplantation of Cultured Autologous Melanocytes on CXCL9, CXCL10 and CXCL11 Expressions in Vitiligo
por: Xu, Chen, et al.
Publicado: (2023)

Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients
por: Li, Yan, et al.
Publicado: (2022)

Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection
por: Karason, Kristjan, et al.
Publicado: (2006)

IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome
por: Maruoka, Hayato, et al.
Publicado: (2013)

High leukocyte mitochondrial DNA copy number contributes to poor prognosis in breast cancer patients
por: Zhang, Wenzhe, et al.
Publicado: (2023)

The association between plasma chemokines and breast cancer risk and prognosis: A mendelian randomization study
por: Yu, Xingxing, et al.
Publicado: (2023)

Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells
por: Fenwick, Peter S., et al.
Publicado: (2015)

High Levels of CXCL8 and Low Levels of CXCL9 and CXCL10 in Women with Maternal RhD Alloimmunization
por: Schettini, Juliana Araújo de Carvalho, et al.
Publicado: (2017)

Subtype-specific associations between breast cancer risk polymorphisms and the survival of early-stage breast cancer
por: Fu, Fangmeng, et al.
Publicado: (2018)

Identification of genes differentially expressed in T cells following stimulation with the chemokines CXCL12 and CXCL10
por: Nagel, JE, et al.
Publicado: (2004)

MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitis
por: Tworek, Damian, et al.
Publicado: (2013)

A meta-analysis of CXCL12 expression for cancer prognosis
por: Samarendra, Harsh, et al.
Publicado: (2017)

Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/CXCR3 Axis: A Review
por: Nazari, Alireza, et al.
Publicado: (2020)

The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression
por: Yin, Xiaowan, et al.
Publicado: (2019)

Polymorphisms of long non-coding RNA HOTAIR with breast cancer susceptibility and clinical outcomes for a southeast Chinese Han population
por: Lin, Yuxiang, et al.
Publicado: (2017)

LncRNA PCIR Is an Oncogenic Driver via Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer
por: Guo, Wenhui, et al.
Publicado: (2021)

HER2 copy number quantification in primary tumor and cell-free DNA provides additional prognostic information in HER2 positive early breast cancer
por: Chen, Xiaobin, et al.
Publicado: (2022)

Myocardial Chemokine Expression and Intensity of Myocarditis in Chagas Cardiomyopathy Are Controlled by Polymorphisms in CXCL9 and CXCL10
por: Nogueira, Luciana Gabriel, et al.
Publicado: (2012)

CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
por: Bronger, Holger, et al.
Publicado: (2016)

CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma—Diagnostic, Therapeutic, and Prognostic Relevance
por: Masouris, Ilias, et al.
Publicado: (2021)

Role of serum CXCL9 and CXCL13 in predicting infection after kidney transplant: A STROBE study
por: Yan, Lin, et al.
Publicado: (2021)

Comment on ‘A meta-analysis of CXCL12 expression for cancer prognosis’
por: Mei, Zu-Bing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cik6uk3478pm178orbivg11rhm